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Neurobiology of Disease

Mitofusin 2 Is Necessary for Transport of Axonal
Mitochondria and Interacts with the Miro/Milton Complex
Albert Misko,1 Sirui Jiang,1 Iga Wegorzewska,1 Jeffrey Milbrandt,1,2 and Robert H. Baloh1,2
1

Department of Neurology and 2Hope Center for Neurological Diseases, Washington University School of Medicine, St. Louis, Missouri 63110

Mitofusins (Mfn1 and Mfn2) are outer mitochondrial membrane proteins involved in regulating mitochondrial dynamics. Mutations in
Mfn2 cause Charcot-Marie-Tooth disease (CMT) type 2A, an inherited disease characterized by degeneration of long peripheral axons,
but the nature of this tissue selectivity remains unknown. Here, we present evidence that Mfn2 is directly involved in and required for
axonal mitochondrial transport, distinct from its role in mitochondrial fusion. Live imaging of neurons cultured from Mfn2 knock-out
mice or neurons expressing Mfn2 disease mutants shows that axonal mitochondria spend more time paused and undergo slower
anterograde and retrograde movements, indicating an alteration in attachment to microtubule-based transport systems. Furthermore,
Mfn2 disruption altered mitochondrial movement selectively, leaving transport of other organelles intact. Importantly, both Mfn1 and
Mfn2 interact with mammalian Miro (Miro1/Miro2) and Milton (OIP106/GRIF1) proteins, members of the molecular complex that links
mitochondria to kinesin motors. Knockdown of Miro2 in cultured neurons produced transport deficits identical to loss of Mfn2, indicating that both proteins must be present at the outer membrane to mediate axonal mitochondrial transport. In contrast, disruption of
mitochondrial fusion via knockdown of the inner mitochondrial membrane protein Opa1 had no effect on mitochondrial motility,
indicating that loss of fusion does not inherently alter mitochondrial transport. These experiments identify a role for mitofusins in
directly regulating mitochondrial transport and offer important insight into the cell type specificity and molecular mechanisms of axonal
degeneration in CMT2A and dominant optic atrophy.

Introduction
As principal mediators of ATP production and calcium buffering, mitochondria actively distribute to areas of high energy demand and calcium flux (Berthold et al., 1993; Li et al., 2004;
Misgeld et al., 2007). Based on this principle, disruption of axonal
transport has long been proposed as a potential mechanism in
human neurodegenerative diseases (Duncan and Goldstein,
2006; De Vos et al., 2008).
Mitochondrial transport is regulated by a series of molecular
adaptors that mediate the attachment of mitochondria to molecular motors (Hollenbeck and Saxton, 2005; Kang et al., 2008; Li et
al., 2009). In Drosophila, connection of mitochondria to kinesin
motors involves the outer mitochondrial membrane (OMM)
protein dMiro, which indirectly attaches to kinesin heavy chain
via the adaptor protein Milton (Guo et al., 2005; Glater et al.,
2006). In mammals, two isoforms of Miro (Miro1 and Miro2)
and Milton (OIP106 and GRIF1) have been identified and are
proposed to act in a similar manner (Fransson et al., 2006).
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In addition to constant movement, mitochondria also undergo frequent fission and fusion events (Chan, 2006). The mitochondrial fusion apparatus consists primarily of mitofusin 1
and mitofusin 2 (Mfn1 and Mfn2) located on the OMM, and
Opa1 located on the inner mitochondrial membrane (Rojo et al.,
2002; Chen et al., 2003; Eura et al., 2003; Wong et al., 2003;
Cipolat et al., 2004). Both the mitofusins and Opa1 are dynamin
family GTPases and are believed to tether opposing membranes
and facilitate their fusion. Although the precise reason for mitochondrial fusion remains unclear, interruption of mitochondrial
fusion (via loss of Opa1 or Mfn1/2) leads to loss of mitochondrial
potential and diminished oxidative phosphorylation, indicating
it is critical for maintaining mitochondrial function (Olichon et
al., 2003; Chen et al., 2005).
Dominantly inherited point mutations in MFN2 are the most
commonly identified cause of axonal Charcot-Marie-Tooth
(CMT) disease (designated CMT2A); however, it is still not clear
how mutations in this ubiquitously expressed protein lead to
relatively selective degeneration of long peripheral axons (Zuchner
et al., 2004; Lawson et al., 2005; Verhoeven et al., 2006). Mutations in OPA1 disrupt mitochondrial fusion and lead to degeneration of optic nerve axons, referred to as dominant optic atrophy
(Votruba et al., 2003; Newman, 2005). In some cases, CMT2A
mutant forms of MFN2 are unable to mediate mitochondrial
fusion in fibroblasts, whereas others are completely competent to
promote fusion (Detmer and Chan, 2007). Interestingly, exogenous expression of disease mutant forms of MFN2 in cultured
sensory neurons leads to a profound abnormality mitochondrial
transport (Baloh et al., 2007), and mice overexpressing disease

Misko et al. • Mfn2 Is Necessary for the Transport of Axonal Mitochondria

J. Neurosci., March 24, 2010 • 30(12):4232– 4240 • 4233

clone was injected into blastocysts to generate
chimeras, and germline transmission was confirmed. Because of either the PGK promoter or
the removal of other endogenous mouse sequences, we found that the chimeric mRNA
transcript was barely detectable, and no HAtagged protein was expressed from the targeted
allele. Living homozygous Mfn2 H361Y/H361Y
mice were not observed from Mfn2 H361Y/⫹ ⫻
Mfn2 H361Y/⫹ breedings. However, timed pregnancies of Mfn2 H361Y/⫹ ⫻ Mfn2 H361Y/⫹ mice
showed embryonic day 12.5 (E12.5) embryos at
25%, indicating that they die between this time
and birth, slightly later than a previously characterized Mfn2-null line (Chen et al., 2003). Immunoblotting of nervous tissue from Mfn2 H361Y/
H361Y embryos showed that no Mfn2 protein was
being generated, indicating that these mice represent a complete knock-out of Mfn2 protein, and
hence we refer to them as Mfn2 ⫺/⫺ in this article.
Dorsal root ganglion cultures. Dorsal root
ganglion (DRG) cultures were performed from
Figure 1. CMT2A-associated MFN2 mutants alter the transport of axonal mitochondria. Mitochondria in cultured DRG neurons embryonic rats or mice on gestational day 15.5
expressing wtMFN2 or R94Q were labeled with mito-RFP and imaged by time-lapse microscopy. A, Kymograph analysis of mito- or 12.5, respectively. Dorsal root ganglia were
chondrial movements in R94Q-expressing cells reveal diminished numbers of moving mitochondria. B, Mitochondria from R94Q- dissected out, dissociated using trypsin/EDTA,
expressing neurons spent more time paused between anterograde and retrograde movements than did mitochondria from and plated directly onto 24-well plates coated
controls. (*p ⬍ 0.005, t test; n ⫽ number of axons from which image stacks were created). Each condition contained a total of at with laminin and poly-D-lysine. Cultures were
least 500 observed mitochondria. C, Velocity distributions representing the amount of time that mitochondria from wtMFN2- or maintained in Neurobasal medium with B27
R94Q-expressing neurons spent moving at indicated velocities. Anterograde velocities are above the x-axis, and retrograde veloc- supplement (Invitrogen), 50 ng/ml NGF, 5 mM
ities are below the x-axis. There was a shift in both the anterograde and retrograde velocity distributions of mitochondria from glutamine, and antibiotics. Addition of
R94Q-expressing neurons toward slower velocities. The differences were statistically significant as determined by rank-sum test 5-fluorouracil for the first 4 d in culture was
analysis ( p ⬍ 0.001). D, Size–frequency distributions of axonal mitochondria from wtMFN2-, R94Q-, and H361Y-expressing cells used as an antimitotic treatment.
show that CMT2A disease mutants decrease mitochondrial lengths.
Lentivirus production and infection. Lentiviruses were produced as described previously
(Baloh et al., 2007). Briefly, human embryonic
mutant MFN2 in motor neurons show markedly abnormal axonal
kidney (HEK) 293T cells were plated onto six-well plates and transfected
mitochondrial distribution (Detmer et al., 2008). These data support
using Mirus reagent with a packaging vector (⌬8.91), envelope vector
(vesicular stomatitis virus-glycoprotein), and transfer vector encoding
that MFN2 influences mitochondrial transport; however, the molecthe gene to be expressed. Media was changed once at 12 h and collected at
ular basis of this effect has not been defined, and it has been observed
24 and 48 h, pooled, and applied directly to DRG cultures resulting in
only in the context of MFN2 overexpression.
⬎95% infection efficiency.
Here, we show that loss of Mfn2 profoundly and selectively
Transfection of DRG cultures. To label mitochondria in a small subset
disrupts axonal mitochondrial transport and that Mfn2 directly
of neurons within a culture, Liptofectamine 2000 (Invitrogen) was used
interacts with OMM proteins and adaptors involved in mitochonaccording to the manufacturer’s specifications to introduce a mitochondridrial transport. Furthermore, we show that disrupting mitochonally targeted DsRed. Briefly, 0.4 g of plasmid DNA was diluted in 25 l of
drial fusion via Opa1 knockdown does not itself disrupt axonal
Opti-MEM (Invitrogen) and combined with 0.5 l of transfection reagent
mitochondrial transport. These data indicate that Mfn2 plays an
diluted in 25 l. The mixture was incubated for 20 min and added to cells.
integral role in the regulation of mitochondrial transport and has
Medium was changed 6 h later to remove the transfection reagent.
important implications for understanding the pathophysiology of
Measurement of mitochondrial transport. For imaging of rat DRG neurons expressing Mfn2 wild-type or disease constructs or silencing RNA
CMT2A and dominant optic atrophy.
constructs, cultures were infected at 4 d in vitro (DIV4) and subsequently
Materials and Methods
transfected with mitochondrial marker on DIV7. Imaging of mitochondrial movements was possible on DIV10 –13. For mouse DRG neurons
Plasmids and silencing RNAs. Human wild-type MFN2 (wtMFN2) and
from Mfn2 ⫺/⫺ mice, infections were performed on DIV4 and infected
MFN2 disease mutant constructs were previously described (Baloh et al.,
again with mitochondrial marker on DIV7. Imaging was then performed
2007). For small interfering RNA (siRNA) constructs, targeting sequences
on DIV10 –13. All imaging was performed in a climate-controlled chamwere generated using the Dharmacon siDesign Center and cloned into the
ber (In Vivo Scientific) at 37°C and 5% CO2 and images were acquired
FSP-si construct as described previously (Araki et al., 2004). Silencing was
with a Cool Snap HQ 2 CCD camera (Photometrics) mounted on a Niconfirmed via quantitative PCR. Myc-tagged Miro1 and Miro2 constructs
kon Eclipse Ti-U microscope. Images were acquired at 40⫻ magnificawere a gift from Dr. Pontus Aspenström (Karolinska Institute, Stockholm,
tion every 1 s for 5 min. Kymographs were then generated and analyzed
Sweden) and were subcloned into a lentiviral expression vector. For Mfn1,
using MetaMorph software (Molecular Devices). Mitochondria were
GRIF1, and OIP106 constructs, cDNAs were obtained from Open Biosysclassified as either moving or stationary based on whether they achieved
tems, and N-terminal tags (His-Mfn1, Flag-GRIF1, and Flag-OIP106) were
a displacement of ⬎2 m. Constant velocity movement segments ideninserted via PCR mutagenesis and sequenced fully.
tified on kymographs were measured for mitochondria that were classiProduction of Mfn2 knock-out mice. A targeting construct that inserted
fied as moving. A velocity cutoff of 0.1 m/s was established, and all
the full-length human MFN2 cDNA with the H361Y mutation and a
movements below this velocity were treated as time spent paused. Meahemagglutinin (HA) tag, as well as a phosphoglycerine kinase (PGK)-neo
surements were pooled, and the time that mitochondria spent moving at
selection cassette, into the first coding exon of mouse Mfn2 was electrogiven velocities was binned and represented on a histogram as a percentporated into mouse embryonic stem cells. Clones were screened for hoage of the total time that mitochondria spent moving above the 0.1 m/s
mologous recombination via Southern blotting, a properly targeted
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cutoff. Pauses in movement segments were measured between consecutive anterograde or retrograde movements and represented as a percentage of the total time that moving mitochondria were observed. In some
cases, images of single axons accompanying kymographs were processed
using the “emboss” filter in Adobe Photoshop for clarity.
Coimmunoprecipitation. HEK 293T cells were transfected using Mirus
with constructs containing His-Mfn1, EGFP-Mfn2, myc-Miro1, mycMiro2, Flag-GRIF1, Flag-OIP106, or Bluescript plasmid as a vector control. Cells were lysed in 1% Triton X-100, 5 mM EDTA, 300 mM NaCl, and
50 mM Tris-HCl, pH 7.5 (Glater et al., 2006), with complete protease
inhibitor mixture (Roche). Cells were lysed at 4°C for 30 min and clarified by spinning at 10,000 ⫻ g, and protein concentration was determined using the BCA protein assay (Thermo Scientific). Equal amounts
of protein from each lysate were raised to a final volume of 500 l,
precleared with protein A Sepharose beads (Invitrogen), incubated with
1 l of anti-myc (Cell Signaling Technology) or anti-Flag (Sigma) antibody for 1 h at room temperature, and then incubated overnight at 4°C
with protein A Sepharose beads. Beads were washed three times with lysis
buffer and boiled in Laemmli buffer before separation by SDS-PAGE.
Western blot analysis was performed with the same antibodies, antiMfn2 (Sigma) or anti-Mfn1 (Novus Biologicals), at a 1:1000 dilution in
5% nonfat milk/TBS-Tween 20.

Results
CMT2A-associated MFN2 mutants disrupt both anterograde
and retrograde mitochondrial transport
Previous studies indicate that CMT2A-associated MFN2 mutants
produce a marked decrease in overall mitochondrial mobility in
axons of cultured sensory neurons (Baloh et al., 2007), and alter
mitochondrial distribution in motor axons of transgenic mice
(Detmer et al., 2008). To clearly define the abnormality in mitochondrial transport in CMT2A mutant-expressing DRG neurons, we introduced wtMFN2 or mutant MFN2 constructs using
lentivirus (⬎99% infection) that were expressed at equal levels
(supplemental Fig. S1, available at www.jneurosci.org as supplemental material), followed by transfection with a mitochondrially targeted RFP that labels only a small number of neurons,
allowing precise analysis of anterograde and retrograde movements in single axons. In wtMFN2-expressing cells, kymograph
analysis of mitochondrial movements consistently depicted
fast persistent movements in both anterograde and retrograde
directions, accompanied by slower moving and stationary mitochondria. In contrast, CMT2A disease mutant MFN2 (R94Q)expressing neurons showed a striking absence of the fast
persistent movements, with the amount of time spent paused
between anterograde and retrograde movements significantly
greater in mutant-expressing neurons than in wtMFN2-expressing
controls (Fig. 1A,B). Additionally, mitochondria from mutantexpressing neurons moved at slower velocities in the anterograde
and retrograde directions (Fig. 1C). These findings indicate that mitochondria in MFN2 mutant-expressing cells were unable to either
initiate or sustain fast processive movements, suggesting a disruption of
microtubule-based mitochondrial transport. We also observed that expression of the R94Q mutant produced smaller fragmented axonal mitochondria, consistent with the previously reported inability of this
mutant to mediate fusion in fibroblasts (Detmer and Chan, 2007). Together, these findings indicate that mutant MFN2 expression influences
both transport and fusion of axonal mitochondria.
CMT2A-associated MFN2 mutants do not alter transport of
other organelles
To determine whether this was a direct effect on mitochondrial
mobility or a global disruption of all organellar transport, we
performed sequential time-lapse imaging of mitochondria and
either endosomes or peroxisomes in single axons of DRG neu-

Figure 2. CMT2A-associated MFN2 mutants specifically disrupt mitochondrial transport.
A, B, DRG neurons expressing the H361Y or R94Q MFN2 disease mutants were coinfected with
mito-RFP (A) and RhoB-GFP (B) mitochondrial and endosomal markers, respectively. Mutantexpressing neurons revealed diminished mitochondrial mobility (A, kymograph) in the same
axons that showed normal endosomal transport (B, kymograph). C, D, The percentage of mobile mitochondria is significantly decreased in R94Q- and H361Y- compared with wtMFN2expressing neurons (*p ⬍ 0.001), whereas the percentage of mobile endosomes in these axons
was normal. E, F, Overlay images of phase contrast and EGFP-SKL (which labels peroxisomes) in
wtMFN2 (E)- and H361Y (F )-expressing DRG axons. G, Similar to endosomes, the percentage of
mobile peroxisomes was unaltered by the expression of MFN2 mutants.

rons expressing wtMFN2 or MFN2 disease mutants (R94Q and
H361Y) (Fig. 2). Axons expressing wild-type or mutant MFN2
were coinfected with a mito-RFP mitochondrial marker (Fig. 2 A)
and a RhoB-green fluorescent protein (GFP) endosomal marker
(Fig. 2 B), and time-lapse imaging with kymograph analysis was
performed on endosomes and mitochondria. Despite the marked
abnormality in mitochondrial transport observed in mutant
MFN2-expressing axons (Fig. 2 A, C), endosomes imaged in the
same axons showed normal movement (Fig. 2 B, D). Similarly,
imaging of peroxisomes (visualized with a GFP-SKL fusion protein) showed normal movement in both wild-type and mutant
MFN2-expressing axons (Fig. 2 E–G). These observations indicate that MFN2 disease mutants specifically alter mitochondrial
transport and do not globally disrupt organellar transport via
alterations in microtubules or intra-axonal signaling pathways.
Mfn2 is required for the proper transport of
axonal mitochondria
The specific disruption of mitochondrial transport by MFN2 disease
mutants suggests that MFN2 may directly regulate microtubulebased mitochondrial transport. To determine whether MFN2 is
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Figure 3. Mfn2 is required for normal axonal transport of mitochondria. To assess the effects of loss of Mfn2 on mitochondrial
mobility, we analyzed mitochondrial transport in DRG neurons cultured from Mfn2 knock-out animals. A–C, DRG cultures from
wild-type (A) or Mfn2 ⫺/⫺ (B) mice infected with mito-RFP and imaged 4 d after infection at 10⫻ magnification coupled with
corresponding kymographs from single axons. Corresponding axons are presented above each kymograph as an embossed image
for clarity. B, Diminished numbers of mitochondria are observed in Mfn2 ⫺/⫺ axons due to a delay in the overall outward migration
of mitochondria that is corrected by reintroduction of wild-type human MFN2 (C, Mfn2 rescue). D, Size–frequency histogram of
mitochondria shows a decrease in the lengths of mitochondria observed in Mfn2 ⫺/⫺ axons that is restored with reintroduction of
MFN2 (Mfn2 rescue). E–G, Kymograph analysis of mitochondrial movements in individual MFN2 ⫺/⫺ axons showed a profound
abnormality in transport, resembling the deficit observed with expression of MFN2 disease mutants. The moving mitochondria
from Mfn2 ⫺/⫺ axons spent more time paused between movements (E, F ) (*p ⬍ 0.001, t test; n is number of axons from which
kymographs were generated), moved at slower velocities in the anterograde and retrograde directions (G), and were completely
rescued by expression of either Mfn2 or Mfn1.

necessary for mitochondrial transport, we cultured DRG neurons
from Mfn2-null (Mfn2 ⫺/⫺) embryos (supplemental Fig. S2,
available at www.jneurosci.org as supplemental material). Lentivirus infection of DRG neurons with mito-RFP showed a marked
delay in the migration of mitochondria out into axons of
Mfn2 ⫺/⫺ neurons compared with DRG neurons from wild-type
littermates (Fig. 3 A, B). As expected, mitochondria from
Mfn2 ⫺/⫺ axons were smaller than controls, consistent with a
mitochondrial fusion defect (Fig. 3D). Live imaging and kymograph

analysis revealed abnormal mitochondrial
movement patterns in Mfn2 ⫺/⫺ neurons
that mirrored the movement abnormalities
seen in MFN2 disease mutant-expressing
neurons (Fig. 3A,B, kymographs). This effect was again specific to mitochondrial
transport, as peroxisomal transport was
normal in these neurons (supplemental
Fig. S3, available at www.jneurosci.org as
supplemental material). Reintroduction
of wild-type MFN2 by lentiviral infection
into Mfn2 ⫺/⫺ cultures fully rescued both
the delay in migration and the abnormal
mitochondrial movement patterns (Fig.
3C, kymograph). Similar to the MFN2
disease mutant-expressing neurons, mitochondria in Mfn2 ⫺/⫺ neurons spent a
greater amount of time paused between
anterograde and retrograde movements
(Fig. 3 E, F ) and more time at slower
velocities in both anterograde and
retrograde directions than in controls
(Fig. 3G).
Interestingly, overexpression of Mfn1
also restored mitochondrial pause time
and velocity distributions to normal levels (Fig. 3 E, F ). Mfn2 and Mfn1 are
highly homologous and are known to
have overlapping functions in mediating
mitochondrial fusion (Chen et al., 2003).
Analysis of Mfn1 and Mfn2 expression in
embryonic fibroblasts and DRG neurons
showed that both Mfn1 and Mfn2 are expressed in DRG neurons, although Mfn2
is higher in neurons than in fibroblasts
(supplemental Fig. S1, available at www.
jneurosci.org as supplemental material).
Therefore, although both are able to
mediate mitochondrial transport, the
severe transport abnormalities in Mfn2 ⫺/⫺
DRG neurons suggest that Mfn1 levels
in these cells are not sufficient to compensate for the loss of Mfn2.
These findings indicate that Mfn2 is
necessary for proper mitochondrial transport and that CMT2A-associated Mfn2
mutants disrupt this function in a
dominant-negative manner. The increased pause time of mitochondria observed in Mfn2 ⫺/⫺ axons suggests that
Mfn2 may either directly promote mitochondrial attachment to microtubules or
maintain the processivity of the microtubule motors kinesin and dynein.

Mfn2 and Mfn1 interact with components of the
mitochondrial transport apparatus
The findings that loss of Mfn2 or expression of CMT2A disease
mutants leads to a selective disruption of fast processive mitochondrial movements suggest that mitofusins could play a
direct role in the regulation of microtubule-based mitochondrial transport. We therefore investigated whether MFN2
could interact with molecules that link mitochondria to
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microtubule-based transport motors.
Miro1 and Miro2 are OMM Rho-like
GTPases that link mitochondria to kinesin, and Drosophila Miro is essential for
mitochondrial transport in flies (Fransson et al., 2006; Glater et al., 2006; Macaskill et al., 2009b; Russo et al., 2009).
Coimmunoprecipitation experiments
demonstrated that Mfn2 and Mfn1 are
capable of interacting with either Miro1
or Miro2 when exogenously expressed
in HEK 293T cells, with an apparently
stronger interaction observed between
Mfn2:Miro2 than Mfn2:Miro1 (Fig.
4 A, B). We next examined OIP106 and
GRIF, homologues of the Drosophila
Milton protein that interacts with both
Miro proteins and kinesin (Fransson et
al., 2006). We found that Mfn2 and
Mfn1 also coimmuniprecipitated with
OIP106 and GRIF1 (Fig. 4C–F). Finally, we
investigated whether the mitofusins directly interact with kinesin. Because
Kif5C, a conventional kinesin-1 superfamily member, is highly expressed in
neurons, we used exogenously expressed
Kif5C for our coimmunoprecipitation experiments but found that neither Mfn2
nor Mfn1 directly interacted with Kif5C
(Fig. 4G,H ). Similarly, no interaction
between Mfn2 and kinesin light chain
was observed (data not shown). To investigate whether Mfn2 could play a role
in “anchoring” mitochondria, we also
examined whether Mfn2 could interact
with syntaphilin (Synph). Synph is an
OMM protein that prevents mitochondria
from moving by anchoring them to microtubules (Kang et al., 2008). However, neither wtMFN2 nor R94Q coimmunoprecipitated
with Synph (Fig. 4I).
These experiments demonstrate that
Mfn2 and Mfn1 interact with components of the kinesin-based mitochondrial
molecular transport apparatus, providing
an explanation for how loss of Mfn2 disrupts mitochondrial transport. Of note,
the CMT2A-associated MFN2 mutants Figure 4. Mfn2 and Mfn1 interact with Miro and Milton proteins, key components of microtubule-based mitochondrial trans(R94Q and H361Y) maintained the ability port. HEK 293T cells were transiently transfected with the indicated epitope-tagged constructs, followed by immunoprecipitation
to interact with Miro1/2 and OIP106/ (IP) and immunoblotting. A, B, Both Mfn2 and Mfn1 were able to interact with Miro1 and Miro2 by coimmunoprecipitation. The
GRIF1 (supplemental Fig. S4, available Mfn2:Miro2 interaction was consistently more robust than the Mfn2:Miro1 interaction, suggesting there may be selectivity for the
at www.jneurosci.org as supplemental formation of this complex. C–F, Mfn2 and Mfn1 interact with the Milton homologues OIP106 and GRIF1, proteins known to
material). Furthermore, mutant MFN2 function as linkers between mitochondria and kinesins motors. G, H, Neither Mfn2 nor Mfn1 coimmunoprecipitated with Kif5C,
proteins did not disrupt either the inter- indicating that they do not directly link mitochondria to kinesin. I, Additionally, Mfn2 was unable to interact with syntaphilin, an
action between OIP106 and kinesin or outer mitochondrial membrane protein that anchors mitochondria to microtubules.
the interaction between Miro2 and
Knockdown of Miro2 produces a mitochondrial transport
OIP106 (supplemental Fig. S4, available at www.jneurosci.org as
abnormality similar to loss of Mfn2
supplemental material). Therefore, the disruption of mitoDrosophila Miro is required for both anterograde and retrograde
chondrial transport observed with disease mutant MFN2 extransport of axonal mitochondria (Guo et al., 2005; Russo et al.,
pression is likely through altered regulation of the kinesin
2009). Although the mammalian Miro proteins interact with
transport apparatus (processivity, attachment to microtuMilton homologues (Fransson et al., 2006), the effect of loss of
bules) rather than simple disruption of Mfn:Miro:OIP106
Miro proteins on axonal mitochondrial transport in mammalian
complex formation.
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diminished oxidative phosphorylation
(Lodi et al., 2004; Chen et al., 2005), it is
possible that the observed alterations in mitochondrial transport could be secondary to
loss of mitochondrial fusion. To investigate
whether diminishing mitochondrial fusion
directly or indirectly disrupts axonal mitochondrial transport, we used lentivirally
delivered siRNA to knockdown Opa1 (supplemental Fig. S1, available at www.
jneurosci.org as supplemental material)
(⬃90% transcript knockdown) in cultured
DRG neurons. Knockdown of Opa1 severely disrupts mitochondrial fusion in
non-neuronal cells, leading to a decrease in
mitochondrial size similar to loss of Mfn1/
Mfn2 (Cipolat et al., 2004; Chen et al.,
2005). Measurement of mitochondrial
lengths confirmed that the mitochondria
were significantly shorter in Opa1 knockdown DRG axons (Fig. 6C), consistent with
the expected decrease in mitochondrial fusion (Cipolat et al., 2004; Chen et al., 2005).
However, time-lapse imaging and kymograph analysis revealed that patterns
Figure 5. Depletion of Miro2 produces a mitochondrial transport abnormality similar to that observed with loss of Mfn2 in DRG
of mitochondrial movement in Opa1
neurons. A, B, Kymograph analysis reveals that siRNA-mediated knockdown of Miro2 dramatically altered patterns of mitochondrial transport. C, Size–frequency histogram of axonal mitochondria demonstrated that depletion of Miro2 altered mitochondrial knockdown neurons were indistinguishable
transport without changing mitochondrial morphology. D, Similar to Mfn2 ⫺/⫺ cultures, mitochondria spent a greater percentage from those of controls (Fig. 6A,B). Mitoof time paused between anterograde movements in Miro2 knockdown cultures (*p ⬍ 0.001, t test; n is the number of axons from chondria in neurons depleted of Opa1 spent
which image stacks were created). Pauses between retrograde movements trended toward longer pause times but did not reach equal amounts of time paused between
statistical significance. E, Mitochondria velocity distributions were also skewed toward slower movements in Miro2 knockdown movements in anterograde and retrograde
cultures, similar to effects seen with loss of Mfn2.
directions and moved at similar velocities
compared with controls (Fig. 6 D, E).
cells has not been examined. We used lentivirally delivered siRThese data indicate that disrupting mitochondrial fusion
NAs to knock down Miro1 or Miro2 (supplemental Fig. S1, availalone via Opa1 knockdown does not itself affect mitochonable at www.jneurosci.org as supplemental material) (⬃70%
drial transport and further supports that Mfn2, via its interactranscript knockdown) in sensory neurons and analyzed the effect
tions with other proteins at the OMM, plays a direct role in
on mitochondrial transport. Knockdown of Miro1 altered mitoregulating mitochondrial transport.
chondrial distribution in the soma but did not affect axonal
mitochondrial transport (supplemental Fig. S5, available at
CMT2A-associated MFN2 mutants cannot compensate for the
www.jneurosci.org as supplemental material). In contrast,
mitochondrial transport abnormality in Mfn2 ⴚ/ⴚ neurons
As described above, studies in fibroblasts have shown that some
knockdown of Miro2 markedly disrupted axonal mitochonCMT2A-associated MFN2 mutants are unable to mediate mitodrial motility (Fig. 5). The pattern of mitochondrial movements
chondrial fusion (R94Q), whereas others are fusion competent
on kymograph analysis was similar to that seen in Mfn2 ⫺/⫺ neurons, with loss of fast, sustained movements (Fig. 5 A, B). Unlike
(L76P, W740S) (Detmer and Chan, 2007). However, exogenous
loss of Mfn2, which produced concurrent mitochondrial fusion
expression of all of these mutants produced a mitochondrial
and transport defects with smaller fragmented mitochondria,
transport deficit in DRG neurons (Baloh et al., 2007), suggesting
loss of Miro2 did not alter the length of axonal mitochondria (Fig.
that the ability of CMT2A mutants to mediate fusion and trans5C). Mitochondria in Miro2-depleted neurons spent more time
port may be separable. To determine whether the role of Mfn2 in
paused between anterograde and retrograde movements, and
mitochondrial fusion could be dissociated from its role in transthe velocity distributions were skewed toward slower velocities
port, we expressed the L76P and W740S mutants (fusion compe(Fig. 5D,E). Of note, overexpression of Miro2 in Mfn2 ⫺/⫺ cultures
tent) and the R94Q mutant (fusion incompetent) in cultured
was not able to rescue transport deficits (data not shown). Together,
Mfn2 ⫺/⫺ neurons and assessed their ability to rescue the transport defect. In contrast to wtMFN2, none of the CMT2Athe fact that Mfn2 interacts directly with the Miro proteins, and that
associated mutants were able to completely normalize the time
loss of Mfn2 or Miro2 disrupts axonal mitochondrial transport in a
mitochondria spent paused between movements or to fully renearly identical manner, suggests that both Mfn2 and Miro2 must be
store the faster movement segments seen on velocity distribupresent for proper axonal mitochondrial transport.
tions (Fig. 7A–C), with the fusion-incompetent R94Q allele being
least capable of rescuing the defect in transport in Mfn2 ⫺/⫺ neuDisruption of mitochondrial fusion by knockdown of Opa1
rons. Therefore, CMT2A MFN2 mutants were not able to nordoes not affect the axonal transport of mitochondria
malize axonal mitochondrial transport in DRG axons whether
Some of the CMT2A disease mutant MFN2 alleles are unable to
they are fusion competent (L76P, W740S) or incompetent
mediate mitochondrial fusion (Detmer and Chan, 2007). Given
(R94Q). This finding indicates that disruption of axonal mitothat loss of mitochondrial fusion leads to dissipation of ⌬ and
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chondrial transport correlates better with
pathogenicity of CMT2A-associated
MFN2 mutants than with the loss of the
ability to mediate mitochondrial fusion.

Discussion
These experiments provide evidence for a
direct role for Mfn2 in mediating mitochondrial transport, distinct from its role in
mitochondrial fusion. Both loss of Mfn2
and expression of CMT2A-associated
MFN2 disease mutants specifically alter mitochondrial movement patterns, causing
mitochondria (but not other organelles)
to move at slower velocities and pause for
greater lengths of time, consistent with
an inability to attach/move via the
microtubule-based kinesin and dynein
transport systems. Together with the finding that mitofusins interact with Miro proteins and OIP106/GRIF1, these data
indicate that Mfn2 is a key component of the
linker/adaptor complex between mitochondria and kinesin/microtubules.
Figure 6.

Disruption of mitochondrial fusion by knockdown of Opa1 does not alter mitochondrial axonal transport. To assess

Mfn2 as a multifaceted regulator of
whether disrupting mitochondrial fusion is itself sufficient to alter mitochondrial transport, we used siRNA to knock down Opa1 in
mitochondrial dynamics and function
DRG neurons. A, B, Embossed images of representative axons and the corresponding kymographs showing Opa1 knockdown
Outer mitochondrial membrane proteins (⬎90%) did not alter mitochondrial movement patterns. C, Mitochondrial size–frequency histogram showed that loss of Opa1
are well positioned to play a key role in co- significantly decreased mitochondrial length similar to that seen in Mfn2 ⫺/⫺ cultures, reflective of decreased mitochondrial
ordinating and regulating diverse aspects of fusion. D, E, Pause times between anterograde or retrograde movements (D) and velocity of movements (E) were not altered by
mitochondrial function. Perhaps it should Opa1 knockdown (n is the number of axons from which kymographs were generated), unlike loss of Mfn2, indicating that loss of
not be a surprise then that mitofusins have mitochondrial fusion alone does not alter mitochondrial transport.
been reported to perform numerous funcal., 1997; Martin et al., 1999; Deacon et al., 2003). The increased
tions, including the regulation of mitochondrial fusion (Chan,
time mitochondria spend paused in axons from neurons lacking
2006), endoplasmic reticulum (ER)–mitochondrial tethering (de
Mfn2 or Miro2 may also indicate a disruption of motor procesBrito and Scorrano, 2008), apoptotic cell death and outer membrane
sivity. Together, this suggests that the Miro2:Mfn2 complex plays
permeability (Suen et al., 2008), oxidative phosphorylation and graa role in regulating the processivity of kinesin motors and in
dient coupling (Pich et al., 2005), and microtubule-based mitochonorchestrating the switch between engaging anterogradely moving
drial transport.
kinesins and retrogradely moving dyneins (Russo et al., 2009).
Our data indicate that regulation of mitochondrial transport
Given the interaction between Miro proteins and mitofusins,
by Mfn2 is achieved by interacting with the Miro:
it is perhaps not surprising that several studies have suggested
Milton complex. The increased pause time and slower movement
that Miro proteins may also influence mitochondrial morpholvelocities in both anterograde and retrograde directions due to
ogy and fusion. Examples include the expression of constitutively
loss of Mfn2 closely resemble the mitochondrial movement abactive Miro1 producing long thread-like mitochondria in COS-7
normalities seen in Miro2-depleted DRG neurons and in dMiro
cells, hippocampal neurons, and H9c2 cells (Fransson et al., 2006;
knock-out flies (Russo et al., 2009). Other reports found that
Saotome et al., 2008; MacAskill et al., 2009a), and the overexpresoverexpression of Miro proteins can either increase (Guo et al.,
sion of dMiro in Drosophila increasing the mean length of axonal
2005) or decrease (Russo et al., 2009) axonal mitochondrial
mitochondria (Russo et al., 2009). These studies highlight the
transport. Importantly, we observed that overexpression of
notion that membrane transport and fusion are intimately reMiro2 could not rescue the transport deficit in Mfn2 ⫺/⫺ neulated processes that must be coordinately regulated to achieve
rons, indicating that both Mfn2 and Miro2 are required to coopproper organellar trafficking, and it is likely that molecular adaperatively mediate mitochondrial transport.
tor complexes at the outer mitochondrial membrane will serve
While Miro proteins have only been shown to interact with
dual roles in transport and fusion.
anterogradely moving kinesin motors, loss of either Mfn2 or
Miro2 led to disruption of both anterograde and retrograde mitochondrial transport, similar to loss of dMiro in flies (Russo et
Alterations in mitochondrial dynamics in human disease
al., 2009). The Mfn:Miro complex may also bind to dynein and
Mitochondrial dysfunction is involved in numerous neurodedirect alternating engagements of either motor with microtubule
generative and metabolic diseases; however, whether mitochontracks. However, this does not have to be the case, as anterograde
drial dysfunction plays a primary role in disease pathogenesis or
and retrograde organellar transports are coordinately regulated,
is simply a consequence of other aspects of cellular dysfunction
and selective disruption of either kinesins or dynein/dynactin
(disruption of protein homeostasis, environmental toxins, etc) is
typically diminishes bidirectional transport, though the exact
unclear. In this context, studying the molecular mechanisms by
which mutations in mitochondrial proteins (such as MFN2 or
reason remains unclear (Brady et al., 1990; Waterman-Storer et
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et al., 2000; Zuchner et al., 2004). However, instead of leading to
identical human diseases, mutations in MFN2 cause a severe peripheral neuropathy affecting the longest axons in the body,
whereas mutations in OPA1 (typically via haploinsufficiency)
predominantly lead to degeneration of optic nerve axons. Our
findings suggest that the fundamental difference in the pathogenesis of these diseases lies in the fact that loss of OPA1 disrupts
mitochondrial fusion without altering mitochondrial transport.
Interestingly, early changes in mitochondrial dynamics are seen
in neurons expressing mutant forms of neurofilament that cause
CMT2E, suggesting that alterations in mitochondrial transport
and distribution may be a final common pathway leading to axonal degeneration in multiple types of CMT (Baloh, 2008;
Tradewell et al., 2009). A viable working hypothesis is that the
long peripheral nerves affected in CMT are more vulnerable to
disruption of mitochondrial transport and distribution than
other cell types. Defining evidence for or against this hypothesis
from patient samples or animal models remains to be demonstrated and is a focus of ongoing research.
Although our studies indicate that Mfn2 is clearly required for
mitochondrial transport, the precise molecular mechanism by
which Mfn2 disease mutants disrupt this process remains unclear, as they maintain the ability to interact with Miro1/2 and
with OIP106/GRIF1. These data indicate the CMT2A disease mutants do not simply disrupt formation of the molecular adaptor
complex linking mitochondria to kinesins, but instead disrupt
the proper function of this complex and, hence, further studies
will be needed to understand exactly how Mfn2 disease mutants
alter the properties of the adaptor complex on a molecular level.

Figure 7. Fusion-competent, CMT2A-associated MFN2 mutants cannot compensate for the
mitochondrial transport abnormality in Mfn2 ⫺/⫺ neurons. To compare the ability of fusioncompetent (L76P, W740S) and fusion-incompetent (R94Q) MFN2 mutants to mediate mitochondrial transport, we reintroduced these mutants into Mfn2 ⫺/⫺ neurons and assessed their
ability to rescue the mitochondrial transport abnormality. As compared with wtMFN2, neither
the fusion-competent (L76P, W740S) nor fusion-incompetent (R94Q) mutants were able to
fully restore mitochondrial pause time (A, B) (n is number of axons from which kymographs
were generated) or mitochondrial velocities (C).

OPA1) cause human disease is helpful, as altered mitochondrial
function likely plays a primary role in disease. One of the fundamental mysteries of inherited neurodegenerative diseases is the
selective vulnerability of particular populations of neurons to
mutations in universally expressed proteins. CMT2A and dominant optic atrophy are associated with mutations in MFN2 and
OPA1, respectively; both are ubiquitously expressed proteins essential for mitochondrial fusion (Alexander et al., 2000; Delettre

The role of Mfn1 and Mfn2 in controlling
mitochondrial dynamics
Alhough Mfn2 and Mfn1 are highly homologous proteins with
overlapping functions, several lines of evidence have shed light on
properties that are divergent between them. Mfn1 more effectively tethers mitochondrial membranes and alone is sufficient to
mediate fusion with Opa1 (Cipolat et al., 2004; Ishihara et al.,
2004). Though both Mfn1- and Mfn2-null mice show early embryonic lethality due to a placental defect (Chen et al., 2003), loss
of Mfn1 outside of the placenta (using a Cre-lox system) led to no
detectable abnormalities, whereas similar nonplacental loss of
Mfn2 caused severe multisystem defects and early postnatal death
(Chen et al., 2007). Additionally, recent evidence suggested that
Mfn2 but not Mfn1 is involved in ER–mitochondrial tethering
(de Brito and Scorrano, 2008).
In our study, loss of Mfn2 alone is sufficient to produce a
severe mitochondrial transport deficit in DRG neurons that
could be restored by expression of either Mfn2 or Mfn1, consistent with the fact that both can interact with the Miro:Milton
complex. Indeed, we found that exogenous expression of
Mfn1 was able to compensate for loss of Mfn2 in DRG neurons, raising the possibility that identifying drugs that would
augment Mfn1 expression may represent a valid therapeutic
strategy for CMT2A.
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